Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
Institute for Disease Modeling, Global Health Division, Bill and Melinda Gates Foundation, Seattle, USA.
Sci Rep. 2021 Jun 4;11(1):11838. doi: 10.1038/s41598-021-91338-5.
Masks are a vital tool for limiting SARS-CoV-2 spread in the population. Here we utilize a mathematical model to assess the impact of masking on transmission within individual transmission pairs and at the population level. Our model quantitatively links mask efficacy to reductions in viral load and subsequent transmission risk. Our results reinforce that the use of masks by both a potential transmitter and exposed person substantially reduces the probability of successful transmission, even if masks only lower exposure viral load by ~ 50%. Slight increases in mask adherence and/or efficacy above current levels would reduce the effective reproductive number (R) substantially below 1, particularly if implemented comprehensively in potential super-spreader environments. Our model predicts that moderately efficacious masks will also lower exposure viral load tenfold among people who get infected despite masking, potentially limiting infection severity. Because peak viral load tends to occur pre-symptomatically, we also identify that antiviral therapy targeting symptomatic individuals is unlikely to impact transmission risk. Instead, antiviral therapy would only lower R if dosed as post-exposure prophylaxis and if given to ~ 50% of newly infected people within 3 days of an exposure. These results highlight the primacy of masking relative to other biomedical interventions under consideration for limiting the extent of the COVID-19 pandemic prior to widespread implementation of a vaccine. To confirm this prediction, we used a regression model of King County, Washington data and simulated the counterfactual scenario without mask wearing to estimate that in the absence of additional interventions, mask wearing decreased R from 1.3-1.5 to ~ 1.0 between June and September 2020.
口罩是限制 SARS-CoV-2 在人群中传播的重要工具。在这里,我们利用一个数学模型来评估口罩对个体传播对和人群水平传播的影响。我们的模型将口罩的功效与病毒载量的降低以及随后的传播风险定量联系起来。我们的研究结果证实,即使口罩只能将暴露的病毒载量降低约 50%,潜在的传播者和暴露者都使用口罩也会大大降低成功传播的可能性。只要稍微提高口罩的佩戴率和/或功效,超过目前的水平,即使在潜在的超级传播环境中全面实施,有效繁殖数(R)也会大大低于 1。我们的模型预测,即使在佩戴口罩的情况下仍被感染的人,口罩也能将暴露的病毒载量降低十倍,这可能会限制感染的严重程度。由于峰值病毒载量往往发生在症状出现之前,我们还发现针对有症状的个体的抗病毒治疗不太可能影响传播风险。相反,如果在暴露后进行预防治疗,并且在暴露后 3 天内给约 50%的新感染人群用药,那么抗病毒治疗只会降低 R。这些结果突出表明,在广泛实施疫苗之前,口罩相对于其他正在考虑的限制 COVID-19 大流行范围的生物医学干预措施具有首要地位。为了证实这一预测,我们使用了华盛顿金县的数据回归模型,并模拟了没有佩戴口罩的反事实情景,以估计在没有其他干预措施的情况下,佩戴口罩将 R 从 2020 年 6 月至 9 月的 1.3-1.5 降低至约 1.0。